Profile Characterization of Biogenic Amines in Glioblastoma Patients Undergoing Standard-of-Care Treatment
Orwa Aboud(University of California, Davis), Oliver Fiehn(University of California, Davis), Rawad Hodeify(Weill Cornell Medical College in Qatar), Yin Liu(Janssen (United States)), Orin Bloch(Neurological Surgery), John Paul Aboubechara(University of California, Davis), Jonathan W. Riess(University of California Davis Medical Center), Ahmad Abuaisheh(Al-Balqa Applied University), Ilias Tagkopoulos(University of California, Davis), Fangzhou Li(University of California, Davis), Lina A. Dahabiyeh(University of Jordan)
Cited by 4
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
|Nature Methods|2015|3.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
A lipidome atlas in MS-DIAL 4
|Nature Biotechnology|2020|901